Impact of Fluid Resuscitation on Venous Congestion in Cardiac Critically-ill Patients
VExUS-CS
1 other identifier
observational
250
0 countries
N/A
Brief Summary
The objective of this study is to assess how fluid resuscitation, in the context of fluid responsiveness, affects the incidence and progression of systemic venous congestion in critically ill cardiac patients. Additionally, the study aims to evaluate the impact on clinical outcomes, with a particular focus on acute kidney dysfunction. This assessment will utilize the VExUS score in conjunction with comprehensive bedside echocardiographic evaluations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2025
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 14, 2025
CompletedStudy Start
First participant enrolled
September 15, 2025
CompletedFirst Posted
Study publicly available on registry
September 19, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
September 19, 2025
September 1, 2025
2 years
September 14, 2025
September 14, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Venous congestion
Venous congestion as assessed by the VExUS score at ICU admission, and on each of the first seven postoperative days.
7 days
Acute kidney injury
Acute kidney injury (AKI), defined through the KDIGO criteria, within seven and twenty-eight days of ICU admission.
Twenty-eight days
Interventions
The VExUS system provides a semi-quantitative assessment of systemic venous congestion by integrating ultrasound evaluations of the inferior vena cava diameter, hepatic vein flow, portal pulsatility, and renal venous flow, offering a practical and comprehensive bedside tool
Eligibility Criteria
Cardiac critically ill patients (mainly post cardiac surgery)
You may qualify if:
- Age above 18 years
- Admission to cardiac intensive care unit
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
Blood Samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.med.
Study Record Dates
First Submitted
September 14, 2025
First Posted
September 19, 2025
Study Start
September 15, 2025
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
September 19, 2025
Record last verified: 2025-09